Baxa Corporation announces that it has unified its US and European operations under a single notified body, the British Standards Institution (BSI), and achieved registration to the ISO-13485:2003 standard. The company recently named BSI as its new registrar and completed its first official assessment with them. BSI assessed Baxa Corporation's management system conformity to ISO-13485:2003,
the upgrade to the ISO-13485:1996 standard to which it had been previously registered.
PR Newswire
Simplifying Global Compliance
Recommended Products
GMP Inspection Preparation Checklist: A Tool for Internal Auditing
This management report includes more than 650 items organized in three sections covering all aspects of quality manufacturing.
Biological Risk Evaluation and Management for Medical Devices
Report shows how the FDA incorporates the two ISO standards in its medical device development policy, how the EU version of the two standards differs in significant ways and how the EU Medical Device Regulation may require further changes in the European standards.
Editor's Picks
CoreLink’s 3D Anterior Lumbar Approved by FDA
The implant allows for better imaging by minimizing material density.
Endo Resumes Lawsuit Against FDA Over Bulk Drug Compounding Decree
The company claimed the agency’s handling of bulk compounding laws violates the 2013 Drug Quality and Security Act, treating the laws as non-binding guidance rather than a legal mandate.
FDAnews Device Daily Bulletin
BAXA CORPORATION REGISTERED TO NEW ISO STANDARD UNDER BSI
May 4, 2006